Current Research Studies

Cancer – APEC1621SC: The Pediatric MATCH Screening Trial

Condition or Therapy:

non-Hodgkin lymphoma, histiocytic disorders, relapsed or refractory advanced solid tumors


Cancer and Blood Disorders
Study Number: APEC1621SC

What is the goal of this study?

The goal of this phase 2 study is to evaluate patients' overall response rate to treatment.

Who can join the study?

This study may be a good fit for children and young adults who:

  • are between the ages of 12 months to 21 years old, and 
  • have a diagnosis of recurrent or refractory solid tumors, including non-Hodgkin lymphomas; histiocytoses (e.g. langerhans cell histiocytosis [LCH], juvenile xanthogranuloma [JXG], histiocytic sarcoma); or central nervous system (CNS) tumors. 

What will happen if my child takes part in this study?

You can read more about this study on

Who can I contact for more information?

To learn more, call 206-987-2106 or email the study coordinator.

Study Location(s):

Seattle Children's Main Hospital Campus

Principal Investigator:

Dr. Sarah Leary
Research Center: Center for Clinical and Translational Research